Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

6.79
-0.3300-4.63%
Pre-market: 7.120.3316+4.88%07:49 EDT
Volume:444.34K
Turnover:3.08M
Market Cap:331.93M
PE:-2.12
High:7.15
Open:7.11
Low:6.77
Close:7.12
52wk High:14.53
52wk Low:2.71
Shares:48.89M
Float Shares:18.98M
Volume Ratio:0.97
T/O Rate:2.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2084
EPS(LYR):-3.4309
ROE:-36.58%
ROA:-22.34%
PB:0.96
PE(LYR):-1.98

Loading ...

Sep 11, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 11, 2026

Major Issues Report

Form 8-K - Current report
Sep 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 10, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 22, 2026

Major Issues Report

Form 8-K - Current report
May 19, 2026

Major Issues Report

Form 8-K - Current report
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 08, 2026

Major Issues Report

Form 8-K - Current report
May 08, 2026

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 08, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]